Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation

Transplantation

Volumn 84, Issue 12 S SUPPL., 2007, Pages

  Yung, Gisella Puga ^a   Valli, Piero V ^a   Starke, Astrid ^a   Mueller, Regula J ^a   Fehr, Thomas ^a   Cesar Özpamir, Marija ^a   Schanz, Urs ^a   Weber, Markus ^a   Wüthrich, Rudolf P ^a   Seebach, Jörg D ^a   Stussi, Georg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

ABO fluorescence activated cell sorting (ABO FACS); ABO incompatible living donor kidney transplantation

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RITUXIMAB;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; BLOOD GROUP O; CASE REPORT; CLINICAL PROTOCOL; CONFERENCE PAPER; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; STANDARD;

ABO BLOOD-GROUP SYSTEM; ADSORPTION; AGGLUTINATION; ANIMALS; BLOOD GROUP INCOMPATIBILITY; CELL SEPARATION; ERYTHROCYTES; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULIN M; KIDNEY TRANSPLANTATION; KINETICS; LIVING DONORS; MALE; MIDDLE AGED; SWINE;

EID: 37549061813     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000296646.17845.12     Document Type: Conference Paper

References (21)

1. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570.
2. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315.
3. Takahashi K. ABO incompatible kidney transplantation. Philadelphia: Elsevier Science, 2001.
4. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089.
5. Tyden G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145.
6. Winters JL, Gloor JM, Pineda AA, et al. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apheresis 2004; 19: 79.
7. Milland J, Sandrin MS. ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens 2006; 68: 459.
8. Lowe JB, Marth JD. Structures common to different types of glycans. In: Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth JD, eds. Essentials of Glycobiology. New York: Cold Spring Harbor Laboratory Press, 1999: 211.
9. Takahashi K, Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 2006; 13: 118.
10. Tanabe K, Takahashi K, Sonda K, et al. Clinicopathological analysis of rejection episodes in ABO-incompatible kidney transplantation. Transplant Proc 1996; 28: 1447.
11. Norden G, Briggs D, Cockwell P, et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006; 13: 148.
12. Galili U. Xenotransplantation and ABO incompatible transplantation: The similarities they share. Transfus Apher Sci 2006; 35: 45.
13. Stussi G, West L, Cooper DK, Seebach JD. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplantation 2006; 13: 390.
14. Stussi G, Huggel K, Lutz HU, et al. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005; 130: 954.
15. Baumann BC, Stussi G, Huggel K, et al. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs. Transplantation 2007; 83: 193.
16. Brecher ME. Technical Manual. Bethesda, MD: American Association of Blood Banks, 2003.
17. Andrew S, Titus J. Induction of immune responses. In: Coligan J, Kruisbeek A, Margulies D, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: Wiley, 1991: 2.7.4.
18. Kumlien G, Ullstrom L, Losvall A, et al. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568.
19. Donauer J, Wilpert J, Geyer M, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A single center experience. Xenotransplantation 2006; 13: 108.
20. Holgersson J, Gustafsson A, Breimer ME. Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies. Immunol Cell Biol 2005; 83: 694.
21. Rydberg L, Bengtsson A, Samuelsson O, et al. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005; 17: 666.